Takeda Ventures was joined in the series B round by venture firms Triathlon Medical Venture Partners and New Science Ventures, which co-led the round. The Global Cardiovascular Innovation Center and venture firms

Italy-based medical device company Sorin Group also has an option to acquire the US-based heart treatment company.

UK-listed investment fund Imperial Innovations joins GlaxoSmithKline's SR One, fund manager Invesco Perpetual and Lundbeckfond Ventures, backing the d cancer treatment company.

The corporate venturing unit of GlaxoSmithKline joins Imperial Innovations, Invesco Perpetual and Lundbeckfond Ventures backing the UK-based cancer treatment company.

News provider Globes said undisclosed Chinese investors were alongside Landa, which was founded in 2002 by Benny Landa, the entrepreneur behind Indigo and its sale to computer maker Hewlett-Packard (HP).

The second round of funding for the UK-based infrared technology company,
deal was led by Robert Bosch Venture Capital, a corporate venturing unit of industrial group Bosch.